KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)

Anti-EGFR therapy appears to be a potential treatment option for squamous cell anal carcinoma (SCAC). KRAS mutation is a rare event in SCAC, indicating the absence of the principal mechanism of resistance to this type of therapy. However, no information is available from the literature regarding the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Casadei Gardini, Andrea, Capelli, Laura, Ulivi, Paola, Giannini, Massimo, Freier, Eva, Tamberi, Stefano, Scarpi, Emanuela, Passardi, Alassandro, Zoli, Wainer, Ragazzini, Angela, Amadori, Dino, Frassineti, Giovanni Luca
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3958420/
https://ncbi.nlm.nih.gov/pubmed/24642661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0092071
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak